210 related articles for article (PubMed ID: 34371958)
1. Dehydroepiandrosterone Shifts Energy Metabolism to Increase Mitochondrial Biogenesis in Female Fertility with Advancing Age.
Li CJ; Lin LT; Tsui KH
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371958
[TBL] [Abstract][Full Text] [Related]
2. The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders.
Lin LT; Wang PH; Wen ZH; Li CJ; Chen SN; Tsai EM; Cheng JT; Tsui KH
Int J Med Sci; 2017; 14(6):585-594. PubMed ID: 28638275
[TBL] [Abstract][Full Text] [Related]
3. Protection of cumulus cells following dehydroepiandrosterone supplementation.
Lin LT; Wang PH; Chen SN; Li CJ; Wen ZH; Cheng JT; Tsui KH
Gynecol Endocrinol; 2017 Feb; 33(2):100-104. PubMed ID: 27684542
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone as a potential agent to slow down ovarian aging.
Lin LT; Cheng JT; Wang PH; Li CJ; Tsui KH
J Obstet Gynaecol Res; 2017 Dec; 43(12):1855-1862. PubMed ID: 28892223
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
7. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
9. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
10. Potential benefit of dehydroepiandrosterone supplementation for infertile but not poor responder patients in a IVF program.
Tartagni M; De Pergola G; Damiani GR; Pellegrino A; Baldini D; Tartagni MV; Alrasheed H; De Salvia MA; Loverro G
Minerva Ginecol; 2015 Feb; 67(1):7-12. PubMed ID: 24867068
[TBL] [Abstract][Full Text] [Related]
11. Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilization.
Keane KN; Hinchliffe PM; Namdar N; Conceicao JL; Newsholme P; Yovich JL
Drug Des Devel Ther; 2015; 9():5569-78. PubMed ID: 26487801
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone plus climen supplementation shows better effects than dehydroepiandrosterone alone on infertility patients with diminished ovarian reserve of low-FSH level undergoing in-vitro fertilization cycles: a randomized controlled trial.
Zhang H; Chu Y; Zhou P; He X; Xu Q; Zhang Z; Cao Y; Wei Z
Reprod Biol Endocrinol; 2016 Feb; 14():9. PubMed ID: 26879683
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Function in Modulating Human Granulosa Cell Steroidogenesis and Female Fertility.
Sreerangaraja Urs DB; Wu WH; Komrskova K; Postlerova P; Lin YF; Tzeng CR; Kao SH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438750
[TBL] [Abstract][Full Text] [Related]
14. DHEA restores mitochondrial dynamics of cumulus cells by regulating PGAM5 expression in poor ovarian responders.
Hou YL; Li CJ; Lin LT; Chen SN; Wen ZH; Tsui KH
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):223-229. PubMed ID: 35361380
[TBL] [Abstract][Full Text] [Related]
15. Does Dehydroepiandrosterone (DHEA) improve in vitro fertilisation (IVF) outcomes in poor responders?
Malini MN; Zain MM
Med J Malaysia; 2020 Jan; 75(1):24-28. PubMed ID: 32008015
[TBL] [Abstract][Full Text] [Related]
16. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial.
Kotb MM; Hassan AM; AwadAllah AM
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():11-5. PubMed ID: 26963897
[TBL] [Abstract][Full Text] [Related]
17. Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques.
Liu X; Wang W; Wang X; Qu Q; Hao C
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():9-13. PubMed ID: 27156150
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.
Tartagni M; Cicinelli MV; Baldini D; Tartagni MV; Alrasheed H; DeSalvia MA; Loverro G; Montagnani M
Reprod Biol Endocrinol; 2015 Mar; 13():18. PubMed ID: 25884390
[TBL] [Abstract][Full Text] [Related]
19. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.
Barad D; Gleicher N
Hum Reprod; 2006 Nov; 21(11):2845-9. PubMed ID: 16997936
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study.
Al-Turki HA
J Int Med Res; 2018 Jan; 46(1):143-149. PubMed ID: 28758852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
